1. DSpace at My University blida 1
  2. Faculté De Médecine
  3. revue
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/16461
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaharboucht, S.-
dc.date.accessioned2022-05-26T17:13:07Z-
dc.date.available2022-05-26T17:13:07Z-
dc.date.issued2021-07-
dc.identifier.issn2676-1858-
dc.identifier.urihttps://di.univ-blida.dz/jspui/handle/123456789/16461-
dc.description.abstractThe Non-Alcoholic Fatty Liver Disease has become in a space of a few years an increasingly frequent pathology in all types of population (general and specific). It is one of the leading causes of chronic liver disease and liver transplants worldwide. Through this article, we will address the most frequent questions relating to this pathology and their answers according to the latest scientific advances in 2021 RÉSUMÉ La stéatopathie métabolique est devenue en espace de quelques années une pathologie de plus en plus fréquente touchant tout type de population (générale et spécifique). Elle est une des premières causes d’hépatopathies chroniques et de transplantations hépatiques dans le monde. A travers cet article, nous aborderons les plus fréquentes questions relatives à cette pathologie et leurs réponses selon les dernières avancées scientifiques de 2021.fr_FR
dc.language.isofrfr_FR
dc.publisherFaculte de Medecine, Universite Blida 1fr_FR
dc.subjectNonalcoholic fatty liver disease, non-invasive diagnosis, NASHfr_FR
dc.subjectStéatopathie métabolique, diagnostic non invasif, NASHfr_FR
dc.titleNon Alcoholic Fatty Liver Disease Frequently Asked Questions (FAQ) in 2021fr_FR
dc.title.alternativeLa stéatopathie métabolique FAQ en 2021fr_FR
dc.typeArticlefr_FR
Appears in Collections:revue

Files in This Item:
File Description SizeFormat 
12.pdf805,5 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.